- Home
- BRAG vs NTHI Comparison
BRAG vs NTHI Comparison
Compare BRAG & NTHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRAG
- NTHI
- Stock Information
- Founded
- BRAG 2018
- NTHI 2008
- Country
- BRAG Canada
- NTHI United States
- Employees
- BRAG N/A
- NTHI N/A
- Industry
- BRAG Office Equipment/Supplies/Services
- NTHI Biotechnology: Pharmaceutical Preparations
- Sector
- BRAG Technology
- NTHI Health Care
- Exchange
- BRAG Nasdaq
- NTHI Nasdaq
- Market Cap
- BRAG 100.8M
- NTHI 110.9M
- IPO Year
- BRAG N/A
- NTHI N/A
- Fundamental
- Price
- BRAG $2.93
- NTHI $5.12
- Analyst Decision
- BRAG Strong Buy
- NTHI
- Analyst Count
- BRAG 3
- NTHI 0
- Target Price
- BRAG $6.67
- NTHI N/A
- AVG Volume (30 Days)
- BRAG 100.2K
- NTHI 320.0K
- Earning Date
- BRAG 08-14-2025
- NTHI 01-01-0001
- Dividend Yield
- BRAG N/A
- NTHI N/A
- EPS Growth
- BRAG N/A
- NTHI N/A
- EPS
- BRAG N/A
- NTHI N/A
- Revenue
- BRAG $123,209,630.00
- NTHI $79,990.00
- Revenue This Year
- BRAG $17.54
- NTHI N/A
- Revenue Next Year
- BRAG $9.33
- NTHI N/A
- P/E Ratio
- BRAG N/A
- NTHI N/A
- Revenue Growth
- BRAG 10.90
- NTHI 13.52
- 52 Week Low
- BRAG $2.86
- NTHI $3.20
- 52 Week High
- BRAG $6.12
- NTHI $25.00
- Technical
- Relative Strength Index (RSI)
- BRAG 16.17
- NTHI N/A
- Support Level
- BRAG $4.01
- NTHI N/A
- Resistance Level
- BRAG $4.20
- NTHI N/A
- Average True Range (ATR)
- BRAG 0.18
- NTHI 0.00
- MACD
- BRAG -0.12
- NTHI 0.00
- Stochastic Oscillator
- BRAG 1.78
- NTHI 0.00
About BRAG Bragg Gaming Group Inc.
Bragg Gaming Group Inc is predominantly a B2B online gaming technology platform and casino content aggregator. The Company's proprietary studios offer high-performing, data-driven casino gaming titles from in-house brands Wild Streak, Spin, Atomic Slot Lab, Indigo Magic, and Oryx Gaming. It offers a full range of games including slot games, table games, card games, video bingo, scratch card games, virtual sports, and live dealer games which are featured on the company's PAM platform and also available for use on other gaming platforms offered by third parties. Geographically, the company generates a majority of its revenue from the Netherlands and the rest from Curacao, Malta, the United States, Croatia, and other regions.
About NTHI NeOnc Technologies Holdings Inc. Common Stock
NeOnc Technologies Holdings Inc. is the developer of a novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. The company product includes NEO100, which commenced Phase 2a clinical trials, which is used for treating glioblastoma, and has Orphan Drug and Fast Track designation from the United States Food and Drug Administration ("FDA").